<?xml version="1.0" encoding="UTF-8"?>
<p id="p0310">Interestingly, the low morbidity and mortality rates of COVID-19 in children might be due to the low secretion threshold of IFNs in children, and the rapid production of IFNs after infection. Thus, the high secretion threshold of IFNs in adults could be responsible for the higher mortality rate in these patients. So, IFN-based therapies might be effective against COVID-19, especially in the early phase of the disease 
 <xref rid="b0640" ref-type="bibr">[128]</xref>.
</p>
